Drug Patent Expirations in September 2015

Drug Patent Expirations for September 2015

TradenameApplicantGeneric NamePatent NumberPatent Expiration
DENAVIRDenco Assetpenciclovir sodium5,840,763Sep 1, 2015
DENAVIRDenco Assetpenciclovir sodium5,916,893Sep 1, 2015
INTEGRILINScheringeptifibatide5,807,825Sep 15, 2015
DEPODURPacira Pharms Incmorphine sulfate5,807,572Sep 15, 2015
SOMAVERTPharmacia And Upjohnpegvisomant6,057,292Sep 21, 2015
DIPRIVANFresenius Kabi Usapropofol5,731,355*PEDSep 22, 2015
DIPRIVANFresenius Kabi Usapropofol5,731,356*PEDSep 22, 2015
DIPRIVANFresenius Kabi Usapropofol5,714,520*PEDSep 22, 2015
DIPRIVANFresenius Kabi Usapropofol5,908,869*PEDSep 22, 2015
KETEKSanofi Aventis UstelithromycinD459798Sep 24, 2015
VALCYTEHoffmann La Rochevalganciclovir hydrochloride6,083,953*PEDSep 29, 2015
DEXFERRUMLuitpoldiron dextran5,624,668Sep 29, 2015
MYCAMINEAstellasmicafungin sodium6,265,536Sep 29, 2015
SYMLINAstrazeneca Abpramlintide acetate5,814,600Sep 29, 2015
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: